As a member of the serpin superfamily of serine protease inhibitors, Serpin G1/C1 inhibitor is the physiological inhibitor of activated C1r and C1s, two serine proteases involved in the classical complement pathway. In addition, it inhibits plasma kallikrein and coagulation factor XIIa, two serine proteases involved in the processing of kininogen to release bradykinin. Therefore, it plays an important role in regulating activation of both the complement and contact systems (1). Serpin G1 deficiency results in hereditary angioedema, which is characterized by recurrent episodes of localized angioedema of the skin, gastrointestinal mucosa or upper respiratory mucosa (2). The deduced amino acid sequence of human Serpin G1 precursor consists of 500 residues with a signal peptide. The mature protein of 478 amino acid residues is heavily glycosylated (1).
Human Serpin G1/C1 Inhibitor (Plasma) Protein, CF
R&D Systems | Catalog # 2488-PI
Key Product Details
- R&D Systems Human Plasma-derived Human Serpin G1/C1 Inhibitor (Plasma) Protein (2488-PI)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
Applications
Product Specifications
Source
The human plasma used for the isolation of this product were certified by the supplier to be HIV-1 and HBsAg negative at the time of shipment. Human blood products should always be treated in accordance with universal handling precautions.
Purity
Endotoxin Level
N-terminal Sequence Analysis
SDS-PAGE
Activity
Measured by its ability to inhibit Recombinant Human Complement Component C1s (Catalog # 2060-SE) cleavage of a colorimetric peptide substrate, N-carbobenzyloxy-Lys-ThioBenzyl ester (Z-K-SBzl).
The IC50 is <2.6 nM, as measured under the described conditions.
Formulation, Preparation, and Storage
2488-PI
| Formulation | Lyophilized from a 0.2 μm filtered solution in Sodium Acetate and NaCl. |
| Reconstitution | Reconstitute at 0.5 mg/mL in sterile, deionized water.
Loading...
|
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Calculators
Background: Serpin G1/C1 Inhibitor
References
- Davis, A.E. III et al. (1993) Methods Enzymol. 223:97.
- Davis, A.E. III (2004) Drug News Perspect. 17:439.
Alternate Names
Entrez Gene IDs
Gene Symbol
Additional Serpin G1/C1 Inhibitor Products
Product Documents for Human Serpin G1/C1 Inhibitor (Plasma) Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Human Serpin G1/C1 Inhibitor (Plasma) Protein, CF
For research use only
Related Research Areas
Citations for Human Serpin G1/C1 Inhibitor (Plasma) Protein, CF
Customer Reviews for Human Serpin G1/C1 Inhibitor (Plasma) Protein, CF
There are currently no reviews for this product. Be the first to review Human Serpin G1/C1 Inhibitor (Plasma) Protein, CF and earn rewards!
Have you used Human Serpin G1/C1 Inhibitor (Plasma) Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Human Serpin G1/C1 Inhibitor (Plasma) Protein, CF (2488-PI):
- Assay Buffer: 50 mM Tris, 10 mM CaCl2, 0.15 M NaCl, and 0.05% Brij-35 (w/v), pH 7.5 (TCNB)
- Human Serpin G1/C1 Inhibitor (hSerpin G1) (Catalog # 2488-PI)
- Recombinant Human Complement Component C1s (rhC1s) (Catalog # 2060-SE)
- Substrate Z-Lys-SBzl (Bachem, Catalog # M-1300), 10 mM in DMSO
- 5,5’-Dithobis(2-Nitrobenzoic acid) (DTNB) (Sigma, Catalog # D-8130), 10 mM in DMSO
- 96-well Clear Plate (Costar, Catalog # 92592)
- Fluorescent Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
- Dilute rhC1s to 2 µg/mL in Assay Buffer.
- Prepare a curve of hSerpin G1 (MW: 93,000 Da) in Assay Buffer. Make the following serial dilutions: 2000, 1000, 500, 100, 50, 25, 12.5, 4, 0.8 and 0.2 nM.
- Combine 25 µL of diluted rhC1s and 25 µL of hSerpin G1 at each concentration of the curve. Include two rhC1s blanks containing Assay Buffer in place of hSerpin G1.
- Incubate mixtures at room temperature for 30 minutes.
- Dilute the mixtures 5-fold by combining 50 µL of reaction mixture with 200 µL Assay Buffer.
- Dilute substrate to 200 μM with Assay Buffer with 200 μM DTNB.
- Load into plate 50 µL of the diluted incubated mixtures, and start the reaction by adding 50 µL of 200 µM substrate/DTNB mixture.
- Read at an absorbance of 405 nm in kinetic mode for 5 minutes.
- Derive the 50% inhibition concentration (IC50) for hSerpin G1 by plotting OD/min (or specific activity) vs. concentration with 4-PL fitting.
- The specific activity for rhC1s at each point may be determined using the following formula (if needed):
|
Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (OD/min) x well volume (L) x 1012 pmol/M |
| ext. coeff** (M-1cm-1) x path corr.*** (cm) x amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Using the extinction coefficient 13260 M-1cm-1
***Using the path correction 0.32 cm
Note: the output of many spectrophotometers is in mOD Per Well: